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ABSTRACT
Objective To assess pain and overall experience of
transvaginal sonography (TVS) in asymptomatic post-
menopausal women.
Methods In the United Kingdom Collaborative Trial
of Ovarian Cancer Screening (UKCTOCS), 50 639
postmenopausal women were randomized to undergo
annual TVS at 13 trial centers in England, Wales and
Northern Ireland. Together with the appointment letter
for their annual scan, a random sample of 150 women per
center was sent a detailed 48-item postal questionnaire
regarding the screening experience. It included a specific
question about pain using a score of 0–5, where 5 was
severe pain and 3 was discomfort. To assess factors that
might affect a woman’s reported pain experience, the
pain score was regressed on age, hormone replacement
therapy use, body mass index, a history of hysterectomy,
prolonged scanning time, ovarian visualization, scan
result, sonographer’s visualization rates and opinion of
the women regarding the sonographer who performed the
scan.
Results Between 7 July and 9 September 2009, 1950
randomly chosen women (150 per regional center)
were sent the questionnaire. Of the 800 (41.0%) who
returned the questionnaire, 651 could be linked to their
TVS appointment. One-hundred and fifty-two (23.3%)
women reported pain/discomfort (score 3–5) during
TVS and 473 (72.7%) reported no discomfort (score
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0–2). Only 23 (3.5%) women reported experiencing
moderate/severe pain. Increasing discomfort/pain was
independently associated with a history of hysterectomy
and participant’s reporting of prolonged scan time.
Women who experienced pain on TVS were less
compliant (odds ratio= 0.87) with the following year’s
scan compared with those who did not experience pain.
Conclusions The majority of postmenopausal women
found TVS acceptable. Pain influenced compliance and
correlated with women’s perception of increased scanning
time and previous hysterectomy. Copyright  2012
ISUOG. Published by John Wiley & Sons, Ltd.
INTRODUCTION
Transvaginal sonography (TVS) is key to ovarian cancer
screening. It is universally used either as the primary
screening modality or as a second-line test following
primary screening with serum CA 1251–4. Although
TVS is a relatively invasive procedure and potentially
embarrassing for the woman, it is increasingly the routine
investigation for assessment of pelvic conditions both
in younger and in older patients5,6. It is preferred over
transabdominal sonography (TAS) as the pelvic organs
are better visualized and, unlike TAS, women are not
required to fill their bladder. Previous studies looking
at the acceptability of TVS have shown that most
women find it acceptable6. However, these studies were
mainly in younger premenopausal women in an early
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pregnancy/obstetrics setting. To our knowledge, there
are currently no published studies specifically exploring
the experience of TVS in postmenopausal women, the
population who will need to undergo annual scanning if
ovarian cancer screening is found to have a mortality
impact4, or in women with postmenopausal bleeding
for whom TVS is the primary line of investigation.
In this older population, it is likely that women may
experience increased discomfort because of atrophic
changes resulting from a hypo-estrogenic status and find
it more intrusive.
We report on pain, acceptability and overall satisfac-
tion with TVS in postmenopausal women from the general
population participating in the United Kingdom Collabo-
rative Trial of Ovarian Cancer Screening (UKCTOCS).
METHODS
In total, 202 638 postmenopausal women were recruited
to the UKCTOCS through 13 regional trial centers
located in National Health Service (NHS) Trusts in Eng-
land, Wales and Northern Ireland. The design of the trial
has been reported previously4,7. Briefly, between April
2001 and October 2005 the women were randomized
to a control group (no screening), a multimodal group
(annual screening with CA 125 as a primary test and TVS
as a secondary test) and an ultrasound group (annual
screening with TVS), in a 2:1:1 ratio; 50 639 women
were randomized to annual screening with ultrasound.
Women were offered TVS as the screening modality
as it offers a superior view of the pelvic organs.
However, when this was not acceptable, TAS was
performed. The scans were undertaken by certified
sonographers, trained midwives, doctors in the NHS
trained in gynecological scanning or experienced certified
gynecologists/radiologists. All scans were performed using
the same model of ultrasound machine and vaginal probe
(Medison Accuvix; Medison, Seoul, South Korea)4.
A 48-item volunteer-satisfaction questionnaire was
developed by the UKCTOCS Ultrasound Subcommittee.
It included questions on waiting times for the scan,
information regarding the scan, experience of undergoing
the scan, pain/discomfort at the scan, interaction with
the sonographer and access to/facilities at the center. The
majority of the questions were dichotomous, with few
questions being open-ended or using a Likert scale. The
key question on discomfort/pain was ‘In your opinion
please grade the pain/discomfort you experienced during
the scan, with ‘0’ being no pain, ‘3’ being discomfort and
‘5’ being severe pain’.
In 2009, the questionnaire was posted to a random
sample of 150 women per center, along with their
appointment letter. It was sent 6 weeks before their
scan appointment. Women were asked to complete the
questionnaire following the scan and to return it in the
enclosed freepost envelope. Women were able to complete
the form anonymously if they so wished.
Annual screening continued in the UKCTOCS until
31 December 2011. The trial management system was
queried to ascertain attendance at future annual screening
appointments for women who returned the completed
questionnaire.
The UKCTOCS study was approved by the UK
North West Multicentre Research Ethics Committees
(North West MREC 00/8/34). It is registered as an
International Standard Randomized Controlled Trial (no.
ISRCTN22488978).
Statistical analysis
Descriptive statistical analysis, including a frequency
table, was undertaken. Based on their reported experience
of pain, women were grouped into two categories: ‘no
pain or discomfort’, which included scores ranging from
0 to 2; and ‘discomfort to severe pain’, which included
scores ranging from 3 to 5. For the model, the reported
experience of pain was imputed as an ordinal variable.
To assess factors that might affect a woman’s reported
pain experience, the pain score (with scores 4 and 5
merged) was regressed on the following: body mass
index (BMI) recorded at recruitment to the trial;
hysterectomy status, obtained by combining data captured
at recruitment and at scan; age at scan; hormone
replacement therapy (HRT) use at scan; perceived time
taken scanning (‘too long’ or not); visualization of
ovaries4; scan result of ovarian assessment (classified as
normal, unsatisfactory or abnormal), both captured on
the scan report; and opinion of the woman regarding
the sonographer who performed the scan, using an
ordinal logistic regression (or proportional odds) model
with backward stepwise selection, with probability of
removal=0.05. The proportional odds model assumes
that the relationship between an explanatory variable and
the dichotomization of the ordinal dependent variable,
for example, pain=0 vs pain =1, 2, 3 or 4, is the same as
that when using any other ordered dichotomization such
as pain= 0 or 1 vs pain= 2, 3 or 4. Hence, only one odds
ratio (OR) is estimated for each explanatory variable.
The competence of the sonographer was assessed (as
per the UKCTOCS quality-assessment measure) by look-
ing at their visualizing rates, calculated as the percentage
of the right ovary seen (the rates for the right ovary
and the left ovary are proportionally similar) out of all
scans they performed during the trial. The visualization
rates for the right ovary only are reported. We compared
the visualization rates between those who scanned the
women who experienced any discomfort/pain (score
3–5) and those who did not experience discomfort/pain
(score 0–2) to explore whether competence affected the
scores. An ordinal logistic model was used to assess
if visualization rates could be used as a predictor of
discomfort/pain.
RESULTS
A random sample of 1950 women (150 per regional
center), selected from 6645 women sent appointment
letters for their annual ultrasound screen between 7
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July and 9 September 2009, were also sent the 48-item
questionnaire. Eight-hundred (41.0%) women returned
the questionnaires, and none was discarded because
of inadequate completion. Of the 697 women who
could be identified, 46 had an abdominal scan only
and were therefore excluded from further analyses. The
remaining 651 had a transvaginal scan. The contribution
of responses from each center ranged from 5.1% to 9.7%.
The baseline characteristics of the 651 women included
in the analysis are reported in Table 1. All were
postmenopausal with a median age of 60.8 (interquartile
range (IQR), 56.1–65.5) years. Most women had
undergone a median of six (range, four to eight) annual
scans previously. The median time from menopause was
10.5 (IQR, 5.3–16.5) years. Although, at recruitment,
126 (19.4%) women were using HRT, when questioned
before the TVS, only 20 (3.1%) reported that they were
still using HRT. Both ovaries were visualized in 423
(65.0%) scans, of which 403 were normal and 20 had
complex morphology requiring a repeat scan as per the
UKCTOCS protocol. In 55 women one or both ovaries
were not visualized, with sonographers obtaining a good
view of the pelvic sidewall in 46 and a poor view, mainly
as a result of bowel gas, in nine.
Four-hundred and seventy-three (72.7%) women
reported experiencing no pain/discomfort during the scan
(score 0–2), and 23 (3.5%) reported moderate/severe
pain (score 4–5) (Table 2). Overall, 152 (23.3%) women
reported some discomfort/pain (score 3–5) but only 64
(42.1%) of these mentioned it to the sonographer.
Six-hundred and thirty-two (97.1%) women were
scanned by a female sonographer, and 596 (91.6%) felt
that they received clear and understandable information
on what to expect at the scan. Six-hundred and thirty-six
(97.7%) women reported that the sonographer behaved
professionally, 607 (93.2%) that they were sensitive and
608 (93.4%) that they were reassuring, and 630 (96.8%)
women reported that they were treated with dignity.
Six-hundred and twenty-seven (96.3%) women felt that
they had enough privacy during the scan. Only 34 (5.2%)
women reported feeling embarrassed during the scan
(Table 3). Only 80 (12.3%) women were shown the
ultrasound monitor screen during the scan, although 317
(48.7%) reported that they would have liked to see the
monitor during the examination (Table 3). In addition,
only 10 (1.5%) women reported waiting over 30 min for
their scan. The majority of the women, 584 (89.7%),
lived within 30 miles of the center, and 561 (86.2%) had
travelled for less than an hour (Table 4). Overall, the
volunteers reported favorably on the facilities at the local
screening center.
Using an ordinal logistic regression model incorporating
discomfort/pain, age, BMI, history of hysterectomy, HRT
use reported at scan and time taken scanning, we found
that hysterectomy significantly increased the odds of
each upwards pain-score transition (going from one
ordered group dichotomization to the next) by 2.42-
fold (95% CI, 1.68–3.50), whilst volunteer-reported
‘prolonged scanning time’ increased the odds by 5.81
times (95% CI, 1.92–17.62). The variables that showed
evidence of being related to pain score when modeled
individually included prior HRT use (OR= 1.36),
hysterectomy (OR= 2.51), prolonged scanning time
(OR= 6.78), abnormal (OR= 2.27) or unsatisfactory
(OR= 1.69) scan result, concern about the scan results
(OR= 1.55) or embarrassment (OR= 1.66). However,
only hysterectomy (OR= 2.42) and prolonged scanning
time (OR= 5.81) were retained in the backward selection
model (Table 5). In an ordinal logistic model using
visualization rates as a predictor of pain, the OR was
1.47 (95% CI, 0.38–5.80; P= 0.574), suggesting that
the visualization rates (as a surrogate for the competence
of the sonographer) did not affect the discomfort/pain
experienced by the women.
Compliance with the following year’s scan in women
who experienced pain on TVS was lower (OR= 0.87;
95% CI, 0.58–1.23; P= 0.379) compared with those
who did not experience pain.
DISCUSSION
Our study shows that TVS is well accepted by the
majority of asymptomatic postmenopausal women
(median age 60.8 (IQR, 56.1–65.5) years), with 23.3%
reporting some discomfort/pain during the procedure
but only 23 (3.5%) reporting moderate/severe pain.
Increased reporting of pain was associated with previous
hysterectomy and women’s perception of prolonged
scanning time. Pain decreased the likelihood of future
attendance for TVS screening.
For a screening strategy to impact on mortality, in
addition to high sensitivity and specificity, the test
needs to be acceptable to those undergoing screening.
Given that TVS is core to all ovarian cancer-screening
strategies8,9, assessing the acceptability of this modality
by older postmenopausal women is important. Our
reported rates of moderate/severe pain of 3.5% are
somewhat higher than the 1.9% reported for young
women undergoing TVS for vaginal bleeding in an early-
pregnancy setting5. While women in both groups may
share apprehensions about the intrusive nature of the test,
higher rates in our cohort probably relate to the age and
the postmenopausal hypo-estrogenic status of women.
In addition, some of the women may not be sexually
active. Data related to sexual activity, collected as part
of the Sussex Health Outcomes Research & Education in
Cancer (SHORE-C), are currently being analyzed10. The
rates of discomfort/pain are much lower in the present
study compared with breast screening, where over 70%
of women described mammography as mild to severely
painful11. Additionally, there may be some selection bias
in the present study as a result of a response rate of only
40% to the questionnaire.
Although some factors showed evidence of being related
to an increased pain score when modeled individually
(previous HRT use, hysterectomy, prolonged scanning
time, abnormal or unsatisfactory scan result, concern
about the scan results or embarrassment), only women’s
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Table 1 Baseline characteristics of women invited to participate in survey on experience of transvaginal sonography (TVS) vs those who
responded
Characteristic
All women invited
(n= 1950)
Responders who had TVS
(n= 651)
Age (years) at randomization 60.3 (55.9–65.5) 60.8 (56.1–65.5)
Years since last period at randomization 10.5 (5.2–17.4) 10.5 (5.3–16.5)
Duration (years) of HRT use in those on HRT at randomization 8.3 (4.6–12.5) 7.6 (4.9–11.4)
Duration (years) of OCP use in those who had used it 5 (2–10) 5 (2–10)
Age at menarche (years) 13 (12–14) 13 (12–14)
Miscarriages (pregnancies< 6 months) 0 (0–1) 0 (0–1)
No. of pregnancies> 6 months 2 (2–3) 2 (2–3)
Height (cm) 162.6 (157.5–165.1) 162.6 (157.5–167.6)
Weight (kg) 67.1 (60.3–76.2) 66.7 (60.3–75.0)
Ethnicity
White 1877 (96.3) 639 (98.2)
Black 27 (1.4) 6 (0.9)
Asian 18 (0.9) 1 (0.2)
Other 18 (0.9) 3 (0.5)
Missing 10 (0.5) 2 (0.3)
Hysterectomy 358 (18.4) 134 (20.6)
Tubal ligation 409 (21.0) 122 (18.7)
Infertility 55 (2.8) 17 (2.6)
Use of OCP (at any point) 1180 (60.5) 393 (60.4)
Use of HRT at recruitment 363 (18.6) 126 (19.4)
Personal history of cancer* 112 (5.7) 33 (5.1)
Personal history of breast cancer 74 (3.8) 25 (3.8)
Maternal history of ovarian cancer 29 (1.5) 7 (1.1)
Maternal history of breast cancer 136 (7.0) 39 (6.0)
Results are given as median (25th –75th centile) or n (%). *Includes those with a personal history of breast cancer. HRT, hormone
replacement therapy; OCP, oral contraceptive pill.
Table 2 Degree of discomfort/pain experienced during transvaginal
ultrasound
Discomfort/pain score n %
0 247 37.9
1 131 20.1
2 95 14.6
3 129 19.8
4 21 3.2
5 2 0.3
Grouped scores
0–2 473 72.7
3–5 152 23.3
Missing data 26 4.0
perception of ‘prolonged’ scanning time and previous
hysterectomy influenced pain in the final model. It needs
to be noted that duration of scanning time was based
on the women’s perception, and the actual scanning time
might be a better measure in future surveys as women’s
reporting could have been affected by the pain response
itself. Factors influencing pain, in women of similar age to
those in the present study, in the screening mammography
study from the Netherlands included sensitive breasts, a
family history of breast cancer, expected pain based on
former mammography, higher education, anxiety and
insufficient attention of the technologist11.
Pain influenced compliance with the following year’s
scan. This is in keeping with the findings from breast
screening that one of the major factors influencing
future non-participation is a painful mammography
experience12. In a survey of women regarding factors
affecting colorectal cancer screening compliance, fear
about screening-related pain was the strongest obstacle to
screening13. It is essential in any screening using TVS that
the scanning protocol includes clear recommendations on
steps to reduce pain if any is experienced during screening.
Given the importance of compliance for a successful and
effective screening program, a detailed analysis of factors
affecting it in both the multimodal (venepuncture for
CA 125) and TVS screening study arms is now underway.
As the competence/skill of the sonographer is a factor
that could influence women’s reporting of discomfort
or pain, we analyzed the sonographer’s visualization
rates. There was no difference between those who
scanned women who reported no pain vs those who
scanned women who reported some level of discom-
fort/pain (75.2%; IQR, 64.1–82.6% vs 74.9%; IQR,
65.8–83.1%) (data not shown). We found that the
visualization rates did not affect the reporting of pain
(OR= 1.47, P= 0.574).
A variety of other factors are likely to influence
continued participation in annual screening. In our study,
the majority of women had a positive opinion regarding
the sonographer who scanned them. In addition to
adequate privacy, the attitude of the staff administering
the test is crucial in intimate examinations, such as TVS.
It is important that women feel that the sonographer is
sensitive and reassuring, and treats them with dignity.
Ninety-seven per cent of the women were scanned by
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Table 3 Women’s view of their experience with the sonographer during transvaginal ultrasound examination
Women (n (%))
Factor assessed Yes No Missing data
Scanned by a female sonographer 632 (97.1) 8 (1.2) 11 (1.7)
Sonographer behaved professionally 636 (97.7) 2 (0.3) 13 (2.0)
Sonographer sensitive to situation 607 (93.2) 18 (2.8) 26 (4.0)
Sonographer reassuring 608 (93.4) 22 (3.4) 21 (3.2)
Received adequate information on what to expect at scan 602 (92.5) 41 (6.3) 8 (1.2)
Received information that was clear and understandable* 596 (91.6) 3 (0.5) 35 (5.4)
Felt had enough privacy 627 (96.3) 13 (2.0) 11 (1.7)
Felt embarrassed during the scan 34 (5.2) 602 (92.5) 15 (2.3)
Treated with dignity 630 (96.8) 5 (0.8) 16 (2.5)
Shown ultrasound monitor screen during scan 80 (12.3) 558 (85.7) 13 (2.0)
Would have liked to be shown screen during scan 317 (48.7) 220 (33.8) 114 (17.5)
*17 women were excluded as they felt this was not applicable in view of previous scans in the trial.
Table 4 Screening-center facilities
Variable n (%)
Distance from center (miles)
1–10 miles 324 (49.8)
11–20 miles 201 (30.9)
21–30 miles 59 (9.1)
>30 miles 49 (7.5)
Missing data 18 (2.8)
Travel time to center (min)
1–30 min 260 (39.9)
31–45 min 200 (30.7)
46–60 min 101 (15.5)
>60 min 80 (12.3)
Missing data 10 (1.5)
Waiting time (min)
None (seen prior to appointment) 154 (23.7)
None (seen at time of appointment) 239 (36.7)
< 15 min 173 (26.6)
15–30 min 60 (9.2)
31–45 min 9 (1.4)
46–60 min 0 (0.0)
> 60 min 1 (0.2)
Missing data 15 (2.3)
Changing area deemed private
Yes 563 (86.5)
No 37 (5.7)
Missing data 51 (7.8)
Changing area deemed clean
Yes 582 (89.4)
No 4 (0.6)
Missing data 65 (10.0)
Changing area close to scanning room
Yes 534 (82.0)
No 3 (0.5)
Missing data 114 (17.5)
a female sonographer. In an earlier UKCTOCS survey,
83.3% of women had expressed a preference for a
female sonographer14. The general consensus is that same-
gender staff are preferred in such situations. This includes
obstetrics settings, with 62% of 1002 pregnant women
(25–40 years of age) preferring a female sonographer15.
In obstetric scanning it is now routine for women
to be shown the monitor. Nearly half of the women
reported that they would have liked to see the monitor
during the examination. In reality, only 12.3% were
shown the ultrasound monitor screen. Inclusion of such
issues in training sessions of staff providing screening is
important.
Other factors affecting continued participation with
screening include distance from the woman’s home to the
center. In the Kentucky Ovarian Cancer Screening Trial,
greater compliance was reported in those living close to
the screening center compared with those living more than
51 miles from the screening center16. In our study, 89.7%
of those sampled lived within 30 miles of the center, with
86.2% having to travel for less than an hour. A comfort-
able and acceptable environment is probably an equally
important issue, with the majority of the women reporting
satisfaction with the facilities provided at the center.
Only 34 (5.2%) women reported feeling embarrassed
during the scan. An older study on sigmoidoscopy sug-
gested using relaxation training ahead of the procedure to
minimize embarrassment17. Providing a calm and relaxed
environment ahead of the scan is probably a strategy
that is likely to reduce embarrassment in postmenopausal
women.
One of the limitations of the study was the relatively
low response rate of 40%. It is possible that as the
questionnaire was sent 6 weeks in advance of the scan
appointment, some women may have misplaced or for-
gotten about it. As the women surveyed had attended four
to eight scans previously in the trial and had a long-term
relationship with the center, it is conceivable that they did
not feel the need to respond to such a survey. In addition,
the survey contained 48 items and some women may have
found it too long and therefore not been inclined to fill it
in. Another limitation of our study was that our analysis of
‘time taken scanning’ was based on the women’s impres-
sion (‘Did you feel the scan took too long?’) rather than
on an actual value, and this might have been biased by her
experience of pain. In similar studies in the future it would
be best to capture the exact time taken to perform the
scan.
In conclusion, postmenopausal women find TVS an
acceptable screening test with only a minority experienc-
ing significant pain. The reporting of pain was increased
in those who had a previous hysterectomy or experienced
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Table 5 Results of ordinal logistic regression model fitted to pain response using various potential explanatory baseline variables and survey
items
Factor Odds ratio 95% CI P
Age 1.00 0.97–1.02 0.798
Hormone replacement therapy 1.36 0.61–3.03 0.460
Body mass index 1.02 0.99–1.06 0.150
Hysterectomy 2.51 1.75–3.60 < 0.001
Scan took too long (‘prolonged’ scanning time) 6.78 2.34–19.56 < 0.001
Ovary seen (left) 0.81 0.59–1.13 0.224
Ovary seen (right) 0.72 0.50–1.03 0.074
Scan result
Normal 1.00
Abnormal 2.27 1.08–4.80 0.031
Unsatisfactory 1.69 0.71–4.02 0.233
Sonographer’s visualization rate 1.47 0.38–5.80 0.574
Sonographer reassuring 0.43 0.19–0.97 0.043
Sonographer sensitive to situation 0.36 0.14–0.93 0.036
Sonographer behaved professionally 0.24 0.00–13.68 0.491
Sonographer gave explanation of procedure 0.47 0.23–0.94 0.034
Sonographer gave explanation of findings 0.70 0.50–0.96 0.028
Sonographer discussed findings after scan 0.68 0.49–0.93 0.017
Sonographer discussed what would happen after scan 0.67 0.44–1.01 0.056
Sonographer told woman that she would return to annual screening 0.59 0.43–0.80 0.001
Woman concerned about results of scan 1.55 0.98–2.46 0.061
Woman felt she had enough privacy 0.62 0.22–1.70 0.349
Woman felt the scan had caused embarrassment 1.66 0.89–3.08 0.108
Woman was shown ultrasound monitor screen 0.57 0.37–0.89 0.014
Woman would have liked to be shown the screen 1.14 0.83–1.57 0.408
Seating deemed adequate 0.51 0.19–1.36 0.178
Woman felt toilet was close by 0.34 0.10–1.19 0.092
Woman felt toilet was clean 0.21 0.06–0.69 0.011
Changing area deemed private 0.88 0.47–1.66 0.691
Changing area deemed clean 0.13 0.02–0.92 0.041
Changing area deemed close to scan room 0.61 0.08–4.53 0.630
Hysterectomy* 2.42 1.67–3.50 < 0.001
Prolonged scanning time* 5.81 1.92–17.62 0.002
*Retained in backward selection model.
a ‘prolonged’ scanning time, and it influenced future
compliance. These data are of value, not only to screening
strategies that may incorporate TVS, but also to older
women undergoing ultrasound scanning in the clinical
setting.
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